{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:56:46Z","timestamp":1786982206085,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T00:00:00Z","timestamp":1627084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T00:00:00Z","timestamp":1627084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s12032-021-01553-3","type":"journal-article","created":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T04:02:50Z","timestamp":1627099370000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19?"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0687-924X","authenticated-orcid":false,"given":"Saptarshi","family":"Sinha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0297-1030","authenticated-orcid":false,"given":"Chanakya Nath","family":"Kundu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,24]]},"reference":[{"issue":"8","key":"1553_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727\u201333. https:\/\/doi.org\/10.1056\/NEJMoa2001017.","journal-title":"N Engl J Med"},{"key":"1553_CR2","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s12098-020-03263-6","volume":"87","author":"T Singhal","year":"2020","unstructured":"Singhal T. A review of coronavirus disease-2019 (COVID-19). Indian J Pediatr. 2020;87:281\u20136. https:\/\/doi.org\/10.1007\/s12098-020-03263-6.","journal-title":"Indian J Pediatr"},{"key":"1553_CR3","unstructured":"World Health Organization. WHO statement regarding cluster of pneumonia cases in Wuhan, China. 2020. https:\/\/www.who.int\/china\/news\/detail\/09-01-2020-who-statement-regarding-cluster-of-pneumonia-cases-in-wuhan-china. Accessed 24 Apr 2021."},{"key":"1553_CR4","unstructured":"World Health Organization. WHO coronavirus disease (COVID-19) dashboard. 2020. https:\/\/covid19.who.int\/. Accessed 06 June 2021."},{"key":"1553_CR5","unstructured":"World Health Organization. Novel coronavirus (2019-nCoV) situation report-11. 2020. https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200131-sitrep-11-ncov.pdf?sfvrsn=de7c0f7_4. Accessed 24 Apr 2021."},{"key":"1553_CR6","unstructured":"World Health Organization. Novel coronavirus (2019-nCoV) situation report-51. 2020. https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10. Accessed 24 Apr 2021."},{"key":"1553_CR7","unstructured":"World Health Organization. COVID-19 weekly operational update on COVID-19. 2021. https:\/\/www.who.int\/publications\/m\/item\/weekly-operational-update-on-covid-19---14-june-2021. Accessed 21 June 2021."},{"key":"1553_CR8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41575-020-0295-7","volume":"17","author":"J Hindson","year":"2020","unstructured":"Hindson J. COVID-19: faecal\u2013oral transmission? Nat Rev Gastroenterol Hepatol. 2020;17:259. https:\/\/doi.org\/10.1038\/s41575-020-0295-7.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10223","key":"1553_CR9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5.","journal-title":"Lancet"},{"key":"1553_CR10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","volume":"20","author":"MZ Tay","year":"2020","unstructured":"Tay MZ, Poh CM, R\u00e9nia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020;20:363\u201374. https:\/\/doi.org\/10.1038\/s41577-020-0311-8.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"1553_CR11","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1158\/2159-8290.CD-20-0422","volume":"10","author":"M Dai","year":"2020","unstructured":"Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z, et al. Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov. 2020;10(6):783\u201391. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-0422.","journal-title":"Cancer Discov"},{"issue":"3","key":"1553_CR12","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","volume":"21","author":"W Liang","year":"2020","unstructured":"Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335\u20137. https:\/\/doi.org\/10.1016\/S1470-2045(20)30096-6.","journal-title":"Lancet Oncol"},{"key":"1553_CR13","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1200\/GO.20.00097","volume":"6","author":"A Desai","year":"2020","unstructured":"Desai A, Sachdeva S, Parekh T, Desai R. COVID-19 and cancer: lessons from a pooled meta analysis. JCO Glob Oncol. 2020;6:557\u20139. https:\/\/doi.org\/10.1200\/GO.20.00097.","journal-title":"JCO Glob Oncol"},{"issue":"7","key":"1553_CR14","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.annonc.2020.03.296","volume":"31","author":"L Zhang","year":"2020","unstructured":"Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan. China Ann Oncol. 2020;31(7):894\u2013901. https:\/\/doi.org\/10.1016\/j.annonc.2020.03.296.","journal-title":"China Ann Oncol"},{"issue":"7","key":"1553_CR15","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1158\/2159-8290.CD-20-0516","volume":"10","author":"V Mehta","year":"2020","unstructured":"Mehta V, Goel S, Kabarriti R, Cole D, Goldfinger M, Acuna-Villaorduna A, et al. Case fatality rate of cancer patients with COVID-19 in a New York hospital system. Cancer Discov. 2020;10(7):935\u201341. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-0516.","journal-title":"Cancer Discov"},{"issue":"7","key":"1553_CR16","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1001\/jamaoncol.2020.0980","volume":"6","author":"J Yu","year":"2020","unstructured":"Yu J, Ouyang W, Chua MLK, Xie C. SARS-CoV-2 transmission in patients with cancer at a Tertiary Care Hospital in Wuhan, China. JAMA Oncol. 2020;6(7):1108\u201310. https:\/\/doi.org\/10.1001\/jamaoncol.2020.0980.","journal-title":"JAMA Oncol"},{"issue":"6","key":"1553_CR17","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1002\/hed.26196","volume":"42","author":"A Bhattacharjee","year":"2020","unstructured":"Bhattacharjee A, Patil VM, Dikshit R, Prabhash K, Singh A, Chaturvedi P. Should we wait or not? The preferable option for patients with stage IV oral cancer in COVID-19 pandemic. Head Neck. 2020;42(6):1173\u20138. https:\/\/doi.org\/10.1002\/hed.26196.","journal-title":"Head Neck"},{"issue":"7798","key":"1553_CR18","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","volume":"579","author":"F Wu","year":"2020","unstructured":"Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265\u20139. https:\/\/doi.org\/10.1038\/s41586-020-2008-3.","journal-title":"Nature"},{"issue":"5","key":"1553_CR19","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41591-020-0868-6","volume":"26","author":"W Sungnak","year":"2020","unstructured":"Sungnak W, Huang N, B\u00e9cavin C, Berg M, Queen R, Litvinukova M, et al. SARSCoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020;26(5):681\u20137. https:\/\/doi.org\/10.1038\/s41591-020-0868-6.","journal-title":"Nat Med"},{"issue":"2","key":"1553_CR20","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kr\u00fcger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271-280.e8. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052.","journal-title":"Cell"},{"issue":"2","key":"1553_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"AC Walls","year":"2020","unstructured":"Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181(2):281-292.e6. https:\/\/doi.org\/10.1016\/j.cell.2020.02.058.","journal-title":"Cell"},{"issue":"4","key":"1553_CR22","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.molcel.2020.04.022","volume":"78","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, P\u00f6hlmann S. A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells. Mol Cell. 2020;78(4):779-784.e5. https:\/\/doi.org\/10.1016\/j.molcel.2020.04.022.","journal-title":"Mol Cell"},{"key":"1553_CR23","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/s41586-020-2312-y","volume":"583","author":"L Bao","year":"2020","unstructured":"Bao L, Deng W, Huang B, Gao H, Liu J, Ren L, et al. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. Nature. 2020;583:830\u20133. https:\/\/doi.org\/10.1038\/s41586-020-2312-y.","journal-title":"Nature"},{"key":"1553_CR24","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.19.049254","author":"C Muus","year":"2020","unstructured":"Muus C, Luecken M, Eraslan G, Waghray A, Heimberg G, Sikkema L, et al. Integrated analyses of single-cell atlases reveal age, gender, and smoking status associations with cell type-specific expression of mediators of SARS-CoV-2 viral entry and highlights inflammatory programs in putative target cells. BioRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.04.19.049254.","journal-title":"BioRxiv"},{"issue":"6","key":"1553_CR25","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41571-020-0366-2","volume":"17","author":"P Sidaway","year":"2020","unstructured":"Sidaway P. COVID-19 and cancer: what we know so far. Nat Rev Clin Oncol. 2020;17(6):336. https:\/\/doi.org\/10.1038\/s41571-020-0366-2.","journal-title":"Nat Rev Clin Oncol"},{"key":"1553_CR26","unstructured":"National Cancer Institute. Age and cancer risk. https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/age. 2021. Accessed 25 May 2021."},{"issue":"4","key":"1553_CR27","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1093\/infdis\/jiaa332","volume":"222","author":"BG Pinto","year":"2020","unstructured":"Pinto BG, Oliveira AE, Singh Y, Jimenez L, Gon\u00e7alves AN, Ogava RL, et al. ACE2 expression is increased in the lungs of patients with comorbidities associated with severe COVID-19. J Infect Dis. 2020;222(4):556\u201363. https:\/\/doi.org\/10.1093\/infdis\/jiaa332.","journal-title":"J Infect Dis"},{"issue":"5","key":"1553_CR28","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.devcel.2020.05.012","volume":"53","author":"JC Smith","year":"2020","unstructured":"Smith JC, Sausville EL, Girish V, Yuan ML, Vasudevan A, John KM, et al. Cigarette smoke exposure and inflammatory signaling increase the expression of the SARS-CoV-2 receptor ACE2 in the respiratory tract. Dev Cell. 2020;53(5):514\u201329. https:\/\/doi.org\/10.1016\/j.devcel.2020.05.012.","journal-title":"Dev Cell"},{"issue":"6","key":"1553_CR29","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1158\/2159-8290.CD-20-0451","volume":"10","author":"KH Stopsack","year":"2020","unstructured":"Stopsack KH, Mucci LA, Antonarakis ES, Nelson PS, Kantoff PW. TMPRSS2 and COVID-19: serendipity or opportunity for intervention? Cancer Discov. 2020;10(6):779\u201382. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-0451.","journal-title":"Cancer Discov"},{"issue":"8","key":"1553_CR30","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.annonc.2020.04.479","volume":"31","author":"M Montopoli","year":"2020","unstructured":"Montopoli M, Zumerle S, Vettor R, Rugge M, Zorzi M, Catapano CV, et al. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n= 4532). Ann Oncol. 2020;31(8):1040\u20135. https:\/\/doi.org\/10.1016\/j.annonc.2020.04.479.","journal-title":"Ann Oncol"},{"issue":"10","key":"1553_CR31","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.annonc.2020.06.023","volume":"31","author":"VG Patel","year":"2020","unstructured":"Patel VG, Zhong X, Liaw B, Tremblay D, Tsao CK, Galsky MD, et al. Does androgen deprivation therapy protect against severe complications from COVID-19? Ann Oncol. 2020;31(10):1419\u201320. https:\/\/doi.org\/10.1016\/j.annonc.2020.06.023.","journal-title":"Ann Oncol"},{"issue":"6","key":"1553_CR32","doi-asserted-by":"publisher","first-page":"e432","DOI":"10.1016\/S2352-3026(20)30123-X","volume":"7","author":"KS Saini","year":"2020","unstructured":"Saini KS, de las Heras B, de Castro J, et al. Effect of the COVID-19 pandemic on cancer treatment and research. Lancet Haematol. 2020;7(6):e432\u20135. https:\/\/doi.org\/10.1016\/S2352-3026(20)30123-X.","journal-title":"Lancet Haematol"},{"issue":"4","key":"1553_CR33","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1152\/physrev.00018.2020","volume":"100","author":"A Sica","year":"2020","unstructured":"Sica A, Colombo MP, Trama A, Horn L, Garassino MC, Torri V. Immunometabolic status of COVID-19 cancer patients. Physiol Rev. 2020;100(4):1839\u201350. https:\/\/doi.org\/10.1152\/physrev.00018.2020.","journal-title":"Physiol Rev"},{"key":"1553_CR34","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","volume":"20","author":"M Merad","year":"2020","unstructured":"Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020;20:355\u201362. https:\/\/doi.org\/10.1038\/s41577-020-0331-4.","journal-title":"Nat Rev Immunol"},{"issue":"6490","key":"1553_CR35","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1126\/science.abb8925","volume":"368","author":"JB Moore","year":"2020","unstructured":"Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020;368(6490):473\u20134. https:\/\/doi.org\/10.1126\/science.abb8925.","journal-title":"Science"},{"issue":"5","key":"1553_CR36","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.ccell.2020.09.018","volume":"38","author":"Z Bakouny","year":"2020","unstructured":"Bakouny Z, Hawley JE, Choueiri TK, Peters S, Rini BI, Warner JL. COVID-19 and cancer: current challenges and perspectives. Cancer Cell. 2020;38(5):629\u201346. https:\/\/doi.org\/10.1016\/j.ccell.2020.09.018.","journal-title":"Cancer Cell"},{"issue":"7","key":"1553_CR37","doi-asserted-by":"publisher","first-page":"e437","DOI":"10.1016\/S2665-9913(20)30121-1","volume":"2","author":"D McGonagle","year":"2020","unstructured":"McGonagle D, O\u2019Donnell JS, Sharif K, Emery P, Bridgewood C. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatol. 2020;2(7):e437\u201345. https:\/\/doi.org\/10.1016\/S2665-9913(20)30121-1.","journal-title":"Lancet Rheumatol"},{"issue":"6","key":"1553_CR38","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1016\/S2213-2600(20)30216-2","volume":"8","author":"RJ Jose","year":"2020","unstructured":"Jose RJ, Manuel A. COVID-19 cytokine storm: the interplay between inflammation and coagulation. Lancet Respir Med. 2020;8(6):e46\u20137. https:\/\/doi.org\/10.1016\/S2213-2600(20)30216-2.","journal-title":"Lancet Respir Med"},{"issue":"5","key":"1553_CR39","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1016\/j.chest.2020.07.031","volume":"158","author":"M Moll","year":"2020","unstructured":"Moll M, Zon RL, Sylvester KW, Chen EC, Cheng V, Connell NT, et al. VTE in ICU patients with COVID-19. Chest. 2020;158(5):2130\u20135. https:\/\/doi.org\/10.1016\/j.chest.2020.07.031.","journal-title":"Chest"},{"issue":"7","key":"1553_CR40","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3390\/ph13070143","volume":"13","author":"F Geisslinger","year":"2020","unstructured":"Geisslinger F, Vollmar AM, Bartel K. Cancer patients have a higher risk regarding COVID-19\u2014and vice versa? Pharmaceuticals (Basel). 2020;13(7):143. https:\/\/doi.org\/10.3390\/ph13070143.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"8","key":"1553_CR41","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1128\/JVI.07012-11","volume":"86","author":"K Bhardwaj","year":"2012","unstructured":"Bhardwaj K, Liu P, Leibowitz JL, Kao CC. The coronavirus endoribonuclease Nsp15 interacts with retinoblastoma tumor suppressor protein. J Virol. 2012;86(8):4294\u2013304. https:\/\/doi.org\/10.1128\/JVI.07012-11.","journal-title":"J Virol"},{"key":"1553_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107247","volume":"90","author":"HJ Han","year":"2021","unstructured":"Han HJ, Nwagwu C, Anyim O, Ekweremadu C, Kim S. COVID-19 and cancer: from basic mechanisms to vaccine development using nanotechnology. Int Immunopharmacol. 2021;90: 107247. https:\/\/doi.org\/10.1016\/j.intimp.2020.107247.","journal-title":"Int Immunopharmacol"},{"key":"1553_CR43","doi-asserted-by":"publisher","first-page":"e00182","DOI":"10.1128\/JVI.00182-17","volume":"91","author":"T Venkataraman","year":"2017","unstructured":"Venkataraman T, Coleman C, Frieman MB. Overactive epidermal growth factor receptor signaling leads to increased fibrosis after severe acute respiratory syndrome coronavirus infection. J Virol. 2017;91:e00182-e217. https:\/\/doi.org\/10.1128\/JVI.00182-17.","journal-title":"J Virol"},{"issue":"2","key":"1553_CR44","doi-asserted-by":"publisher","first-page":"188356","DOI":"10.1016\/j.bbcan.2020.188356","volume":"1873","author":"B Piersma","year":"2020","unstructured":"Piersma B, Hayward MK, Weaver VM. Fibrosis and cancer: a strained relationship. Biochim Biophys Acta Rev Cancer. 2020;1873(2):188356. https:\/\/doi.org\/10.1016\/j.bbcan.2020.188356.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"1553_CR45","doi-asserted-by":"publisher","first-page":"592891","DOI":"10.3389\/fonc.2020.592891","volume":"10","author":"F Francescangeli","year":"2020","unstructured":"Francescangeli F, De Angelis ML, Baiocchi M, Rossi R, Biffoni M, Zeuner A. COVID-19\u2013induced modifications in the tumor microenvironment: do they affect cancer reawakening and metastatic relapse? Front Oncol. 2020;10:592891. https:\/\/doi.org\/10.3389\/fonc.2020.592891.","journal-title":"Front Oncol"},{"key":"1553_CR46","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13058-020-01360-0","volume":"22","author":"F Francescangeli","year":"2020","unstructured":"Francescangeli F, De Angelis ML, Zeuner A. COVID-19: a potential driver of immune-mediated breast cancer recurrence? Breast Cancer Res. 2020;22:117. https:\/\/doi.org\/10.1186\/s13058-020-01360-0.","journal-title":"Breast Cancer Res"},{"key":"1553_CR47","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.28.122291","author":"CA Stewart","year":"2020","unstructured":"Stewart CA, Gay CM, Ramkumar K, Cargill KR, Cardnell RJ, Nilsson MB, et al. Lung cancer models reveal SARS-CoV-2-induced EMT contributes to COVID-19 pathophysiology. bioRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.05.28.122291.","journal-title":"bioRxiv"},{"key":"1553_CR48","doi-asserted-by":"publisher","first-page":"100406","DOI":"10.1016\/j.ctarc.2021.100406","volume":"28","author":"Y Saygideger","year":"2021","unstructured":"Saygideger Y, Sezan A, Candevir A, Demir BS, Guzel E, Baydar O, et al. COVID-19 patients\u2019 sera induce epithelial mesenchymal transition in cancer cells. Cancer Treat Res Commun. 2021;28:100406. https:\/\/doi.org\/10.1016\/j.ctarc.2021.100406.","journal-title":"Cancer Treat Res Commun"},{"issue":"10","key":"1553_CR49","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1001\/jamaoncol.2020.2367","volume":"6","author":"MB Abid","year":"2020","unstructured":"Abid MB, Mughal M, Abid MA. Coronavirus disease 2019 (COVID-19) and immune-engaging cancer treatment. JAMA Oncol. 2020;6(10):1529\u201330. https:\/\/doi.org\/10.1001\/jamaoncol.2020.2367.","journal-title":"JAMA Oncol"},{"key":"1553_CR50","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41571-020-0375-1","volume":"17","author":"H Nagar","year":"2020","unstructured":"Nagar H, Formenti SC. Cancer and COVID-19\u2014potentially deleterious effects of delaying radiotherapy. Nat Rev Clin Oncol. 2020;17:332\u20134. https:\/\/doi.org\/10.1038\/s41571-020-0375-1.","journal-title":"Nat Rev Clin Oncol"},{"key":"1553_CR51","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41571-020-0370-6","volume":"17","author":"J Spicer","year":"2020","unstructured":"Spicer J, Chamberlain C, Papa S. Provision of cancer care during the COVID-19 pandemic. Nat Rev Clin Oncol. 2020;17:329\u201331. https:\/\/doi.org\/10.1038\/s41571-020-0370-6.","journal-title":"Nat Rev Clin Oncol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-021-01553-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-021-01553-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-021-01553-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T02:47:25Z","timestamp":1629773245000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-021-01553-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,24]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["1553"],"URL":"https:\/\/doi.org\/10.1007\/s12032-021-01553-3","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.740535529.793589370","asserted-by":"object"}]},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,24]]},"assertion":[{"value":"21 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was not required for this review article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"101"}}